Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain

Completed

• Conditions: Severe, Chronic Pain
• Interventions: Drug: Matrifen

• Registration Number: NCT00556270
• Lead Sponsor: Nycomed

Brief Summary

The aim of the study is to evaluate the efficacy and safety of matrifen in patients with severe and chronic pain who can only be sufficiently treated with opioid analgesics (WHO class 3).

Detailed Description

Not available

Study Timeline

• Study Start: 2007-11
• Study First Submitted: 2007-11-08
• Study First Submitted QC: 2007-11-08
• Study First Posted: 2007-11-09
• Study Completion: 2008-05
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-04
• Last Update Posted: 2012-05-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Matrix II	Matrifen	-

Primary Outcome Measures

Name	Time	Method
Treatment success, efficacy of Matrifen	within 1 month

Secondary Outcome Measures

Name	Time	Method
Safety and tolerability of fentanyl and the transdermal system, quality of life	within 1 month

Trial Locations

Locations (1)

"Nycomed Deutschland GmbH"; 🇩🇪 Zühlsdorf, Germany